Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyglandular autoimmune syndrome type II]

T Császár1, A Patakfalvi

  • 1Zala Megyei Onkormányzat Kórház-Rendelöintézete, I. Belgyógyászat, Zalaegerszeg.

Orvosi Hetilap
|July 18, 1993
PubMed
Summary

A rare polyglandular autoimmune syndrome type II developed in a young woman after a viral infection, leading to severe immunthrombocytopenia. Cyclosporin therapy achieved total remission, highlighting its potential in treating this rare condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cyclosporin-A therapy in autoimmune diseases].

Orvosi hetilap·1996
Same author

[Differential diagnostic problems in Lyme disease (Borrelia infection resulting in acute exogenous psychosis)].

Orvosi hetilap·1994
Same author

[Smoldering myeloma].

Orvosi hetilap·1993
Same author

[Successful treatment of hemorrhaging necrotizing pancreatitis with peritoneal dialysis].

Orvosi hetilap·1993
Same author

[Successful treatment of hyperthyroidism simulating acute abdomen and psychosis].

Orvosi hetilap·1992
Same author

Treatment of polyglandular autoimmune syndrome with cyclosporin-A.

Acta medica Hungarica·1992

Area of Science:

  • Endocrinology
  • Immunology
  • Hematology

Background:

  • Polyglandular autoimmune syndrome type II (PAS II) is a rare autoimmune disorder affecting multiple endocrine glands.
  • Viral infections can sometimes trigger autoimmune responses, leading to complex clinical presentations.

Observation:

  • A young woman developed progressive endocrine disorders over four years following a viral infection.
  • She subsequently developed severe immunthrombocytopenia, a condition characterized by low platelet counts due to autoimmune processes.

Findings:

  • The patient was diagnosed with the rare polyglandular autoimmune syndrome type II.
  • Initial treatment with steroid therapy proved insufficient, and severe bleeding due to thrombocytopenia necessitated further intervention.
  • Cyclosporin therapy was initiated and resulted in a complete remission of the syndrome.

Implications:

  • This case highlights the potential for viral infections to precipitate rare autoimmune endocrine disorders.
  • Cyclosporin therapy demonstrated significant efficacy in achieving remission for this patient with PAS II and severe immunthrombocytopenia.
  • The successful treatment underscores the importance of considering novel therapeutic approaches for rare autoimmune conditions.

Related Experiment Videos